0.4570
-0.0020
(-0.44%)
At close: January 31 at 4:22:26 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-31,222.0000
-31,222.0000
-27,984.0000
-18,426.0000
-11,694.0000
Investing Cash Flow
-17.0000
-17.0000
-541.0000
-32.0000
-403.0000
Financing Cash Flow
--
--
--
32,550.0000
37,610.0000
End Cash Position
13,403.0000
13,403.0000
44,894.0000
72,942.0000
58,577.0000
Capital Expenditure
-17.0000
-17.0000
-541.0000
-32.0000
-403.0000
Issuance of Capital Stock
--
--
--
32,550.0000
37,610.0000
Free Cash Flow
-31,239.0000
-31,239.0000
-28,525.0000
-18,458.0000
-12,097.0000
12/31/2020 - 11/24/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPAGO.ST Spago Nanomedical AB (publ)
0.2520
-4.55%
NANECH.ST NanoEcho AB
0.1386
-1.00%
PCIB.OL PCI Biotech Holding ASA
1.2500
+2.12%
XSPRAY.ST Xspray Pharma AB (publ)
33.70
-1.03%
BIOVIC-B.ST Biovica International AB (publ)
2.1750
+3.57%
BGBIO.OL BerGenBio ASA
7.90
-1.04%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1744
-2.90%
ATORX.ST Alligator Bioscience AB (publ)
0.0404
+24.31%
VICO.ST Vicore Pharma Holding AB (publ)
9.09
-0.76%
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%